Good news for CMT 1A and 1B

InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of Oral IFB-088 For more informations, follow the link: https://bit.ly/2QNzl9W … Continue reading Good news for CMT 1A and 1B